Drug · DIN 00344923
DIPROSONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 16, 2022; first marketed December 31, 1976.
- Drug Identification Number (DIN)
- 00344923
- Company (DIN owner)
- Organon Canada Inc.Kirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Ointment
- Route
- Topical
- Therapeutic class (ATC)
- Betamethasone D07AC01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BETAMETHASONE (BETAMETHASONE DIPROPIONATE) | 0.05 % | W/W |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 9, 2021: NOC 25639New Drug Submission (NDS) · Change in product ownership
- February 25, 2011: NOC 12106New Drug Submission (NDS) · Manufacturer name change
Other DINs named DIPROSONE
- DIN 00323071 · Marketed
- DIN 00417246 · Marketed